Lonza News ١١ مارس ٢٠٢٦ Lonza Expands Agreement to Manufacture Gene Therapy for Transfusion-Dependent Beta-Thalassemia - GEN - Genetic Engineering and Biotechnology News
Lonza News ١٠ مارس ٢٠٢٦ Lonza Divests Capsules & Health Ingredients Business for $3 Billion - CHEManager
Lonza News ٩ مارس ٢٠٢٦ Lonza and Genetix Biotherapeutics Extend Commercial Manufacturing Agreement for ZYNTEGLO - the-scientist.com
Lonza News ٩ مارس ٢٠٢٦ Lone Star Funds to acquire Lonza’s Capsules & Health Ingredients - Nutrition Insight
Lonza News ٩ مارس ٢٠٢٦ Lonza to Become Pure-play Pharma Contract Developer With CHF2.3 Billion Sale of Capsules, Ingredients Division - marketscreener.com
Lonza News ٩ مارس ٢٠٢٦ Lonza: Lone Star Funds To Acquire Capsules & Health Ingredients Division - Pulse 2.0
Lonza News ٨ مارس ٢٠٢٦ Lone Star Funds to Acquire the Capsules & Health Ingredients Division of Lonza Group AG - citybiz
Lonza News ٧ مارس ٢٠٢٦ Will Lonza Group AG (Common Stock) (LO3A) stock beat growth indexes - Short Setup & Smart Investment Allocation Tips - Naître et grandir
Lonza News ٦ مارس ٢٠٢٦ Lonza sells capsule and health ingredients unit to UK's Lone Star for $2.2B - Endpoints News
Lonza News ٦ مارس ٢٠٢٦ Lonza Seals CHF 2.3 Billion CHI Sale to Complete Shift to Pure-Play CDMO - TipRanks
Lonza News ٦ مارس ٢٠٢٦ Lonza to sell capsule and health ingredients business to Lone Star for $3.0 billion - Reuters